Copyright: ©Author(s) 2026.
World J Exp Med. Sep 20, 2026; 16(3): 121518
Published online Sep 20, 2026. doi: 10.5493/wjem.121518
Published online Sep 20, 2026. doi: 10.5493/wjem.121518
Table 1 Clinical applications of bone-specific alkaline phosphatase
| Clinical scenario | BSAP pattern | Clinical interpretation | Utility |
| Anabolic therapy | ↑ Early rise | Increased osteoblast activity | Early response marker |
| Antiresorptive therapy | ↓ Decrease | Reduced bone turnover | Monitor treatment |
| Fracture healing | ↑ Peak at 6-12 weeks | Callus formation | Assess healing |
| Osteoporosis | ↑ Or normal | High vs low turnover | Guide therapy |
| Paget’s disease | ↑↑ Markedly elevated | Excess bone formation | Diagnosis and monitoring |
| Osteomalacia | ↑ | Defective mineralization | Diagnostic support |
| CKD bone disease | ↑ or ↓ | Turnover differentiation | Clinical decision-making |
- Citation: Thirunavukkarasu PJ, Gunasekar A, Jeyaraman N, Nallakumarasamy A, Devanand V, Bharadwaj S, Jeyaraman M. Bone-specific alkaline phosphatase as a marker of bone formation: Clinical and imaging correlates. World J Exp Med 2026; 16(3): 121518
- URL: https://www.wjgnet.com/2220-315x/full/v16/i3/121518.htm
- DOI: https://dx.doi.org/10.5493/wjem.121518